Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Dow
Medtronic
Farmers Insurance
Harvard Business School
Covington
Johnson and Johnson
Colorcon
Federal Trade Commission
Chinese Patent Office

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,604,463

« Back to Dashboard

Summary for Patent: 4,604,463
Title: Camptothecin derivatives and process for preparing same
Abstract:New camptothecin derivatives possessing high anti-tumor activity with slight toxicity, represented by the general formula: ##STR1## wherein R.sup.1 is a hydrogen atom, a halogen atom or an alkyl group with 1-4 carbon atoms and X is a chlorine atom or --NR.sup.2 R.sup.3 where R.sup.2 and R.sup.3 are the same or different and each represents a hydrogen atom, a substituted or unsubstituted alkyl group with 1-4 carbon atoms or a substituted or unsubstituted carbocyclic or heterocyclic group, with the proviso that when both R.sup.2 and R.sup.3 are the substituted or unsubstituted alkyl groups, they may be combined together with the nitrogen atom, to which they are bonded, to form a heterocyclic ring which may be interrupted with --O--, --S-- and/or >N--R.sup.4 in which R.sup.4 is a hydrogen atom, a substituted or unsubstituted alkyl group with 1-4 carbon atoms or a substituted or unsubstituted phenyl group and wherein the grouping --O--CO--X is bonded to a carbon atom located in any of the 9-, 10- and 11-positions in the ring A of camptothecin, as well as an ammonium salt or an alkali metal salt thereof. These new camptothecin derivatives are prepared by reacting a 7-R.sup.1 -camptothecin derivative having a hydroxyl group in any of the 9-, 10- and 11-positions on the ring A thereof with phosgen and then reacting, if necessary, the resultant 7-R.sup.1 -camptothecin derivative having a chlorocarbonyloxy group in the same position on the ring A thereof with an amine HNR.sup.2 R.sup.3 or by reacting a 7-R.sup.1 -camptothecin derivative having a hydroxyl group in any of the 9-, 10- and 11-positions on the ring A thereof with a carbamoyl chloride Cl-CONR.sup.2 R.sup.3.
Inventor(s): Miyasaka; Tadashi (Kanagawa, JP), Sawada; Seigo (Tokyo, JP), Nokata; Kenichiro (Tokyo, JP), Sugino; Eiichi (Tokyo, JP), Mutai; Masahiko (Tokyo, JP)
Assignee: Kabushiki Kaisha Yakult Honsha (Tokyo, JP)
Application Number:06/627,980
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 4,604,463

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,604,463

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan58-126946Jul 14, 1983

International Patents Family Members for US Patent 4,604,463

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 33839 ➤ Subscribe
Canada 1235415 ➤ Subscribe
Germany 137145 ➤ Subscribe
Germany 3470744 ➤ Subscribe
European Patent Office 0137145 ➤ Subscribe SPC/GB97/010 United Kingdom ➤ Subscribe
Japan H034077 ➤ Subscribe
Japan S6019790 ➤ Subscribe
Luxembourg 90074 ➤ Subscribe
Netherlands 980026 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
US Department of Justice
Farmers Insurance
Boehringer Ingelheim
Colorcon
Federal Trade Commission
Accenture
Covington
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot